Further Validation of the Crohn’s and Ulcerative Colitis Questionnaire-32 (CUCQ-32) to Measure the Quality of Life in Patients Treated with Biologics Therapy
Alrubaiy, L.; Sikafi, R.; Hutchings, H.A.; Arnott, I.; Williams, J.G. Further Validation of the Crohn’s and Ulcerative Colitis Questionnaire-32 (CUCQ-32) to Measure the Quality of Life in Patients Treated with Biologics Therapy. Clin. Pract. 2022, 12, 436-448. https://doi.org/10.3390/clinpract12030048
Alrubaiy L, Sikafi R, Hutchings HA, Arnott I, Williams JG. Further Validation of the Crohn’s and Ulcerative Colitis Questionnaire-32 (CUCQ-32) to Measure the Quality of Life in Patients Treated with Biologics Therapy. Clinics and Practice. 2022; 12(3):436-448. https://doi.org/10.3390/clinpract12030048
Chicago/Turabian StyleAlrubaiy, Laith, Rafid Sikafi, Hayley A. Hutchings, Ian Arnott, and John G. Williams. 2022. "Further Validation of the Crohn’s and Ulcerative Colitis Questionnaire-32 (CUCQ-32) to Measure the Quality of Life in Patients Treated with Biologics Therapy" Clinics and Practice 12, no. 3: 436-448. https://doi.org/10.3390/clinpract12030048